Skip to main content

Biotech is beating health care by double this year—here's how one investor would play it

Biotechnology stocks have soared in the fourth quarter, with the group's year-to-date gain doubling that of the broader health-care sector, and investing pros have found a few ways to capitalize.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.